# India Life Science Tools Market > India Life Science Tools Market Research Report By End User (Biopharmaceutical Company, Government Academic Industry, Health Care, Others), By Product (NGS, Sanger Sequencing, Nucleic Acid Preparation, Nucleic Acid Microarray, PCRq PCR, Flow Cytometry, Mass Spectrometry, Separation Technologies, Electron Microscopy, NMR, Others) and By Technology (Genomic Technology, Cell Biology Technology, Proteomics Technology, Lab Supplies Technologies, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 11.3% - **2024:** $ 7 Billion - **2025:** $ 7.79 Billion - **2035:** $ 22.72 Billion - **Key Players:** Thermo Fisher Scientific (US), Abbott Laboratories (US), Agilent Technologies (US), Danaher Corporation (US), Merck KGaA (DE), PerkinElmer (US), Bio-Rad Laboratories (US), Illumina (US), Roche Holding AG (CH) **Report ID:** MRFR/LS/43860-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-life-science-tools-market-45540 --- ## Market Summary ## India Life Science Tools Market Overview As per MRFR analysis, the India Life Science Tools Market Size was estimated at 7.86 (USD Billion) in 2024. The India Life Science Tools Market Industry is expected to grow from 9.5 (USD Billion) in 2025 to 30.0 (USD Billion) by 2035. The India Life Science Tools Market CAGR (growth rate) is expected to be around 11.02% during the forecast period (2025 - 2035). ### Key India Life Science Tools Market Trends Highlighted The India Life Science Tools Market is experiencing significant growth driven by several key market drivers which include an increasing focus on research and development in healthcare and pharmaceutical sectors. The government of India has been actively promoting scientific research through initiatives like the 'National Biotechnology Development Strategy,' which aims to enhance the country’s position in biotechnology. This increased investment fosters innovation and the development of advanced tools in life sciences, benefiting both research institutions and the commercial sector. Opportunities to be explored in the Indian life science tools market are abundant, particularly in the realm of diagnostics and personalized medicine. With the rising prevalence of chronic diseases and the increasing demand for quality healthcare, there is a growing need for efficient tools that can aid in disease understanding and prevention. Moreover, the burgeoning start-up ecosystem in India is also contributing to the creation of innovative life science tools, as these companies focus on addressing unique market needs and harnessing technology to improve research outcomes. Trends in recent times highlight a shift towards the integration of artificial intelligence and automation in life science tools. This trend is driven by the need for more efficient data analysis and experimental procedures, enabling researchers to make quicker and more informed decisions. Enhanced connectivity in laboratories, along with the adoption of cloud-based solutions, is changing how researchers in India access and share vital data. As awareness of sustainability increases, there is also a notable movement towards developing eco-friendly and energy-efficient life science tools, aligning with broader environmental goals set forth by the Indian government. Overall, the India life science tools market is poised to expand significantly, driven by innovation, increasing collaboration, and a growing demand for advanced scientific solutions. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ## India Life Science Tools Market Drivers ### Growing Demand for Advanced Molecular Diagnostics The India Life Science Tools Market industry is experiencing significant growth due to an increasing demand for advanced molecular diagnostics. The prevalence of chronic diseases, such as diabetes and cardiovascular diseases, has surged in India. According to the Indian Ministry of Health and Family Welfare, the nation witnessed approximately 77 million diabetes cases in 2019, projected to reach 134 million by 2045. Companies like Roche and Siemens Healthineers have been investing heavily in molecular diagnostics tools adapted for the Indian market, making them more accessible. This push aligns with government initiatives aimed at improving healthcare access and diagnostic facilities, ultimately fostering an environment for growth in the life science tools sector. ### Surge in Government Funding for Healthcare Research The increase in government funding specifically aimed at healthcare research significantly drives the India Life Science Tools Market industry. Recent policy reforms by the Indian government have included a 10% increase in the healthcare budget, focusing on the biotechnology and pharmaceutical sectors. Such investments have spurred innovation among local biopharma firms, aiding their journey toward developing advanced life science tools. For instance, organizations like Biocon and Serum Institute of India benefit directly from this funding, facilitating faster R&D and product introductions, thereby expanding the market for life science tools. Technological Advancements and Digital Transformation The rapid pace of technological advancements and digital transformation in the healthcare sector plays a crucial role in the growth of the India Life Science Tools Market industry. Innovations in AI and big data analytics are becoming integral to the life sciences, enabling faster and more accurate research results. A report from NITI Aayog suggests that the use of digital technologies can reduce healthcare costs by up to 30%, making advanced tools more viable for Indian labs and hospitals. Companies like Thermo Fisher Scientific and Agilent Technologies are at the forefront, developing smart lab solutions that cater specifically to the Indian healthcare landscape. ## India Life Science Tools Market Segment Insights: ### Life Science Tools Market End User Insights The India Life Science Tools Market has seen significant evolution, particularly in the End User segment that caters to diverse fields such as Biopharmaceuticals, Government Academic Institutions, Health Care, and other industries. This segment plays a crucial role in shaping market dynamics due to the increasing demand for advanced research tools in biopharmaceutical companies, which are pivotal for drug discovery and development, especially in the context of India's burgeoning pharmaceutical sector. The Government Academic Institutions are also essential contributors, driving research and innovation in various life sciences, emphasizing the importance of collaboration between public and private sectors to enhance scientific progress. Moreover, the Health Care segment is gaining momentum due to the rising focus on diagnostics, personalized medicine, and health monitoring technologies, thus emphasizing the need for reliable life science tools to ensure effective patient care. The 'Others' category encompasses a wide range of applications across industries such as environmental monitoring, food safety, and agriculture, which are experiencing rapid advancements and integration of life science tools to ensure compliance and quality standards. Overall, the End User segment reflects a landscape of interconnected industries that are increasingly reliant on cutting-edge life science tools, which facilitate research, enhance productivity, and stimulate growth across the board in India. The India Life Science Tools Market industry stands as a testament to this ongoing evolution, offering ample opportunities and challenges that various end users must navigate to capitalize on market growth while addressing the needs and priorities inherent to their specific fields. Collectively, these factors underscore the overarching significance of the End User segment in the broader scenario of the India Life Science Tools Market, as each participant contributes uniquely to the development of innovative tools that drive advancements in science and health. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ### Life Science Tools Market Product Insights The India Life Science Tools Market is experiencing substantial growth, driven by advancements in technology and increasing research activities within the life sciences sector. The Product segment showcases diverse areas, such as Next-Generation Sequencing (NGS), which has gained prominence due to its high-throughput capabilities, enabling researchers to sequence DNA rapidly and cost-effectively. Sanger Sequencing remains crucial in validating results from newer technologies because of its accuracy. Nucleic Acid Preparation and Microarray are critical for effective genomic studies, supporting the growing demand for personalized medicine in India. The PCR qPCR techniques stand out for their essential roles in diagnostics and research, reflecting the increasing demand driven by the COVID-19 pandemic and beyond. Flow Cytometry offers significant applications in cell analysis, improving research in immunology, oncology, and more. Mass Spectrometry is important for biomolecule characterization, driving innovations in proteomics and metabolomics. Separation Technologies play a pivotal role in purifying biological samples, which is crucial for experimental integrity. In this vibrant market landscape, these areas collectively support the burgeoning life sciences research ecosystem in India, positioning the country as a key player in global scientific advancement. The continued focus on enhancing research capabilities, alongside government initiatives, further fuels the growth of these essential tools within the India Life Science Tools Market. ### Life Science Tools Market Technology Insights The Technology segment of the India Life Science Tools Market encompasses a diverse array of tools and techniques that are pivotal for modern research and development in life sciences. Genomic Technology plays a critical role, significantly bolstering advancements in personalized medicine and genetic research, thus driving innovations in diagnostics and therapeutics. Cell Biology Technology remains essential in understanding cellular processes, contributing to the development of new treatments for various diseases. Similarly, Proteomics Technology supports the study of protein functions and interactions, which is crucial for drug discovery and development. Lab Supplies Technologies serve as foundational elements, ensuring efficient and accurate experimental outcomes for researchers. The increasing investments in healthcare and biotechnology sectors in India have further fueled the growth of these technologies, facilitating collaborative research and enhancing infrastructural capabilities. Major key players in the industry focus on developing cutting-edge tools that address the evolving needs of laboratories across the country, which is vital for propelling advancements in the India Life Science Tools Market. This segment, guided by technological advancements and an increasing commitment to health-related research, showcases promising opportunities for growth and development in the coming years. ## India Life Science Tools Market Key Players and Competitive Insights: The India Life Science Tools Market is characterized by a dynamic competitive landscape marked by innovation and the evolution of technology. As the country experiences growth in the biomedical and pharmaceutical sectors, various companies are actively positioning themselves to cater to the increasing demand for advanced life science tools. The market has seen substantial investments in research and development, targeting areas such as genomics, proteomics, and molecular diagnostics. This has resulted in a robust array of products and services being offered by both established players and new entrants. Companies within this market are focusing on collaboration and partnerships to enhance their offerings and maintain a competitive edge while also addressing various regulatory challenges that are unique to the Indian landscape. Qiagen holds a significant position in the India Life Science Tools Market due to its comprehensive product portfolio that includes sample preparation technologies and assays. The company has developed a reputation for high-quality and reliable products, making it a preferred choice for both academic and commercial laboratories in India. Qiagen's strengths lie in its ability to adapt to the local market needs, offering customized solutions to research institutions and diagnostic centers. Its robust distribution network and strategic partnerships enhance its market presence, allowing Qiagen to effectively deliver innovative life science solutions while also providing technical support and training to end-users. This strong alignment with the evolving market trends enables Qiagen to maintain its competitive advantage in India. PerkinElmer has established a strong foothold in the India Life Science Tools Market by providing a diverse range of products and services tailored for the healthcare and life sciences sectors. The company specializes in advanced imaging systems, diagnostics, and analytical instrumentation, which are vital for research and quality control in laboratories. PerkinElmer's strengths include its commitment to innovation and customer-centric solutions, with a significant focus on enhancing research capabilities through its cutting-edge technology. The company actively engages in collaborations and partnerships within India to drive growth and expand its market share. PerkinElmer's involvement in several mergers and acquisitions has further strengthened its portfolio, enabling it to offer integrated solutions that meet the specific needs of Indian customers. Through its focused approach and dedication to scientific advancement, PerkinElmer continues to contribute significantly to the burgeoning life science tools sector in India. ### Key Companies in the India Life Science Tools Market Include: ### India Life Science Tools Market Industry Developments The India Life Science Tools Market has seen significant recent developments, notably in the growth and acquisition strategies of major players like Thermo Fisher Scientific and Becton Dickinson. In September 2023, Thermo Fisher Scientific announced a strategic expansion into India, aiming to enhance its manufacturing capabilities and operational presence in the region. Becton Dickinson has also reinforced its market position by launching innovative solutions tailored for Indian laboratories, which is expected to boost local research capabilities. Notably, in October 2022, PerkinElmer acquired an Indian diagnostic company, a move that showcased its commitment to the growing life science and diagnostics market in India. The market valuation for life science tools in India has been bolstered by increasing investments in biotechnology and healthcare, driven by initiatives from the Indian government to promote RD. Companies like Merck Group and Agilent Technologies have reported robust growth metrics, with the market anticipated to grow further due to rising demand for high-quality research tools. These developments indicate a dynamic landscape characterized by both innovation and strategic collaborations among industry leaders, fostering a conducive environment for advancement in life sciences within India. ## India Life Science Tools Market Segmentation Insights ### India Life Science Tools Market End User Outlook ### India Life Science Tools Market Product Outlook ### India Life Science Tools Market Technology Outlook ## Market Drivers ### Regulatory Support for Innovation Regulatory frameworks in India are increasingly supportive of innovation within the life science-tools market. The government has implemented policies aimed at streamlining the approval processes for new medical devices and tools. This regulatory environment encourages research and development, allowing companies to bring innovative products to market more efficiently. For instance, the Medical Device Rules introduced in 2017 have facilitated a more structured approach to product registration. As a result, the life science-tools market is likely to benefit from a faster introduction of cutting-edge technologies, which can enhance diagnostic and therapeutic capabilities in healthcare settings. ### Growing Demand for Diagnostic Tools The life science-tools market in India is experiencing a notable surge in demand for diagnostic tools. This trend is largely driven by the increasing prevalence of chronic diseases and the need for early detection. According to recent data, the diagnostic segment is projected to grow at a CAGR of approximately 10% over the next five years. The rise in healthcare awareness among the population is also contributing to this growth. As healthcare facilities expand and modernize, the demand for advanced diagnostic equipment is likely to increase. This shift not only enhances patient outcomes but also propels the life science-tools market forward, as manufacturers strive to innovate and meet the evolving needs of healthcare providers. ### Expansion of Biopharmaceutical Sector The biopharmaceutical sector in India is expanding rapidly, which is positively impacting the life science-tools market. With the increasing focus on biologics and biosimilars, there is a growing need for specialized tools and technologies that support biopharmaceutical research and production. The market for biopharmaceuticals is expected to reach $100 billion by 2025, indicating a robust growth trajectory. This expansion necessitates advanced life science tools for research, quality control, and manufacturing processes. Consequently, companies in the life science-tools market are likely to see increased demand for their products as they cater to the needs of this burgeoning sector. ### Emphasis on Training and Skill Development There is a growing emphasis on training and skill development within the life science-tools market in India. As new technologies emerge, the need for skilled professionals who can effectively utilize these tools becomes increasingly critical. Educational institutions and industry players are collaborating to develop training programs that equip individuals with the necessary skills. This focus on human capital development is likely to enhance the overall efficiency and effectiveness of the life science-tools market. By ensuring that the workforce is well-trained, the market can better meet the demands of healthcare providers and researchers, ultimately leading to improved patient care and outcomes. ### Rising Investment in Healthcare Infrastructure Investment in healthcare infrastructure in India is on the rise, which is expected to have a substantial impact on the life science-tools market. The government and private sector are allocating significant funds to enhance healthcare facilities, including laboratories and research institutions. This investment is projected to increase by approximately 15% annually over the next few years. As healthcare infrastructure improves, the demand for advanced life science tools will likely grow, as these tools are essential for research, diagnostics, and treatment. This trend indicates a promising future for the life science-tools market as it aligns with the broader goals of improving healthcare access and quality. ## Future Outlook The [Life Science Tools Market](https://www.marketresearchfuture.com/reports/life-science-tools-market-12273) in India is projected to grow at 11.3% CAGR from 2025 to 2035, driven by technological advancements, increased R&D investments, and rising healthcare demands. **New opportunities:** - Development of AI-driven diagnostic tools for personalized medicine. - Expansion of automated laboratory systems to enhance efficiency. - Introduction of portable biosensors for rapid field testing applications. By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in innovation. ## Segment Insights ### By End-User: Biopharmaceutical Company (Largest) vs. Health Care (Fastest-Growing) The India life science-tools market displays a diverse distribution among its end-user segments. The biopharmaceutical company segment holds the largest share, reflecting the robust growth of biopharma in the region. In contrast, the government & academic industry and health care sectors are also significant, with the health care segment rapidly gaining traction as institutions focus on enhancing patient care and research capabilities. Growth in the end-user segments is driven by increased investments in biopharmaceuticals and technological advancements in health care. The demand for innovative life science tools is accelerating as companies vie to improve outcomes. Additionally, government initiatives aimed at enhancing research and academic collaboration are propelling the government's role, making it a substantial player in this space. Biopharmaceutical Company (Dominant) vs. Health Care (Emerging) The biopharmaceutical company segment stands as a dominant force within the India life science-tools market, characterized by significant investments in R&D and a focus on developing advanced therapies. This segment leverages cutting-edge technologies and collaborative efforts to drive innovation. Conversely, the health care segment is emerging rapidly, spurred by the rise of digital health solutions and an increased emphasis on personalized medicine. Health care providers are adopting life science tools to improve diagnostic accuracy and patient outcomes, showcasing a shift towards a more integrated, technology-driven approach that complements the established dominance of biopharmaceutical companies. ### By Product: PCR & qPCR (Largest) vs. Nucleic Acid Preparation (Fastest-Growing) The India life science-tools market displays a diverse array of product segments, each contributing uniquely to the overall landscape. PCR & qPCR has established itself as the largest segment, commanding a significant share due to its critical applications in diagnostics and research. Following closely are NGS and Sanger Sequencing, which also hold substantial market shares, though their growth rates do not match that of Nucleic Acid Preparation, which is gaining momentum rapidly. As the demand for precision medicine and personalized therapies increases, segments like Nucleic Acid Preparation are poised for sharper growth. Factors influencing this trend include advancements in genomics, the rising prevalence of chronic diseases, and an increase in government funding for biotech research. Furthermore, the introduction of innovative technologies within these segments is facilitating more efficient workflows and enhancing research capabilities, which is likely to accelerate growth over the coming years. PCR & qPCR (Dominant) vs. Nucleic Acid Preparation (Emerging) PCR & qPCR serves as a cornerstone in the India life science-tools market, utilized extensively in various applications such as clinical diagnostics, infectious disease detection, and genetic research. Its dominance is attributed to established protocols, a wide user base, and consistent advancements that enhance its sensitivity and specificity. In contrast, Nucleic Acid Preparation is emerging rapidly due to its crucial role in sample preparation for NGS and other genomic analyses. The increased focus on high-throughput sequencing projects and research into gene therapies is driving this segment's growth. As laboratories transition towards more integrated and automated solutions, Nucleic Acid Preparation is likely to see a significant uptick in adoption and innovation. ### By Technology: Genomic Technology (Largest) vs. Proteomics Technology (Fastest-Growing) In the India life science-tools market, the distribution of market share among the technology segments is quite diverse, with genomic technology holding the largest portion due to its integral role in research and diagnostics. Following this, cell biology technology and proteomics technology also contribute significantly, while lab supplies and technologies, along with others, cater to specialized needs within the market. Growth trends indicate that while genomic technology remains dominant, proteomics technology is emerging as the fastest-growing segment, driven by increased research in personalized medicine and biotechnology. The continual advancements in lab technologies and the rising demand for efficient workflows are propelling the growth of cell biology and proteomics technologies, indicating a shift towards more integrated solutions in life science research. Technology: Genomic Technology (Dominant) vs. Proteomics Technology (Emerging) Genomic technology is characterized by its foundational role in genomics research, enabling scientists to understand genetic variations and their implications in health. With widespread applications in diagnostics and therapeutics, this segment dominates the market due to its established methodologies and extensive adoption by research institutions. In contrast, proteomics technology is rapidly rising, driven by innovations in mass spectrometry and bioinformatics. As researchers increasingly focus on understanding protein functions and interactions, proteomics is becoming an essential tool in drug discovery and development. Both segments are crucial, yet their market dynamics reflect a blend of traditional dominance and emerging opportunities. ## Competitive Benchmarking The life science-tools market in India is characterized by a dynamic competitive landscape, driven by innovation, technological advancements, and strategic partnerships. Major players such as Thermo Fisher Scientific (US), Abbott Laboratories (US), and Agilent Technologies (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Thermo Fisher Scientific (US) focuses on expanding its product portfolio through continuous innovation, while Abbott Laboratories (US) emphasizes strategic collaborations to enhance its diagnostic capabilities. Agilent Technologies (US) is investing in digital transformation initiatives to streamline operations and improve customer engagement, collectively shaping a competitive environment that prioritizes technological advancement and customer-centric solutions.Key business tactics employed by these companies include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of key players like Merck KGaA (DE) and Danaher Corporation (US) is notable, as they leverage their extensive resources and expertise to drive growth and innovation in the sector. In October Thermo Fisher Scientific (US) announced the launch of a new line of advanced genomic analysis tools aimed at enhancing research capabilities in genomics. This strategic move is likely to strengthen its position in the rapidly evolving field of personalized medicine, reflecting a commitment to innovation and addressing the growing demand for genomic solutions in India. In September Abbott Laboratories (US) expanded its partnership with local healthcare providers to enhance access to its diagnostic tools across rural regions. This initiative not only demonstrates Abbott's commitment to improving healthcare accessibility but also positions the company favorably in a market increasingly focused on equitable healthcare solutions. In August Agilent Technologies (US) unveiled a new cloud-based platform designed to facilitate real-time data sharing among researchers. This strategic action underscores Agilent's focus on digital transformation and its potential to enhance collaboration within the scientific community, thereby driving innovation and efficiency in research processes. As of November current competitive trends in the life science-tools market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances are becoming increasingly vital, as companies seek to leverage complementary strengths to enhance their offerings. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, technological advancements, and supply chain reliability, indicating a shift towards a more sophisticated and resilient market landscape. ## Recent News & Developments The India Life Science Tools Market has seen significant recent developments, notably in the growth and acquisition strategies of major players like Thermo Fisher Scientific and Becton Dickinson. In September 2023, Thermo Fisher Scientific announced a strategic expansion into India, aiming to enhance its manufacturing capabilities and operational presence in the region. Becton Dickinson has also reinforced its market position by launching innovative solutions tailored for Indian laboratories, which is expected to boost local research capabilities. Notably, in October 2022, PerkinElmer acquired an Indian diagnostic company, a move that showcased its commitment to the growing life science and diagnostics market in India. The market valuation for life science tools in India has been bolstered by increasing investments in biotechnology and healthcare, driven by initiatives from the Indian government to promote RD. Companies like Merck Group and Agilent Technologies have reported robust growth metrics, with the market anticipated to grow further due to rising demand for high-quality research tools. These developments indicate a dynamic landscape characterized by both innovation and strategic collaborations among industry leaders, fostering a conducive environment for advancement in life sciences within India. ## India Life Science Tools Market Segmentation Insights ### India Life Science Tools Market End User Outlook ### India Life Science Tools Market Product Outlook ### India Life Science Tools Market Technology Outlook ## Report Scope | MARKET SIZE 2024 | 7.0(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 7.79(USD Billion) | | MARKET SIZE 2035 | 22.72(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.3% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Thermo Fisher Scientific (US), Abbott Laboratories (US), Agilent Technologies (US), Danaher Corporation (US), Merck KGaA (DE), PerkinElmer (US), Bio-Rad Laboratories (US), Illumina (US), Roche Holding AG (CH) | | Segments Covered | End-User, Product, Technology | | Key Market Opportunities | Advancements in genomics and personalized medicine drive growth in the life science-tools market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the life science-tools market in India. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the current valuation of the India life science-tools market?** A: The market valuation was $7.0 Billion in 2024. **Q: What is the projected market size for the India life science-tools market by 2035?** A: The market is expected to reach $22.72 Billion by 2035. **Q: What is the expected CAGR for the India life science-tools market during the forecast period 2025 - 2035?** A: The expected CAGR is 11.3% from 2025 to 2035. **Q: Which companies are the key players in the India life science-tools market?** A: Key players include Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, and others. **Q: What segment had the highest valuation in the end-user category in 2024?** A: The Biopharmaceutical Company segment had the highest valuation at $2.1 Billion. **Q: How much is the Health Care segment projected to grow by 2035?** A: The Health Care segment is projected to grow to $7.0 Billion by 2035. **Q: Which product segment is expected to see the most growth by 2035?** A: The PCR & qPCR segment is expected to grow to $3.34 Billion by 2035. **Q: What is the valuation of the Genomic Technology segment in 2024?** A: The Genomic Technology segment was valued at $1.4 Billion in 2024. **Q: How does the projected growth of the Lab Supplies & Technologies segment compare to others?** A: The Lab Supplies & Technologies segment is projected to grow to $6.5 Billion by 2035, indicating strong growth. **Q: What trends are influencing the growth of the India life science-tools market?** A: Trends include advancements in genomic technology and increasing investments in biopharmaceuticals. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-life-science-tools-market-45540*